Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- SELF-MEDICATION NEWS IN BRIEF
July 4, 2005
- MEDICAL DEVICE NEWS IN BRIEF
July 4, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 4, 2005
- NEW PRODUCTS
July 4, 2005
- R&D NEWS IN BRIEF
July 4, 2005
- PEG-IFN + Ribavirin Effective against Hepatitis C: Society Meeting
July 4, 2005
- Large-scale Clinical Trial to Assess Primary Preventive Effects of Aspirin
July 4, 2005
- 7th Meeting of Japanese Society of Clinical Pharmacological Studies
July 4, 2005
- BUSINESS NEWS IN BRIEF
July 4, 2005
- JGPMA Formally Accepted as Observer at IGPA
July 4, 2005
- JCR Pharmaceuticals Expects to Launch Generic EPO in 2009 or 2010
July 4, 2005
- Blopress Is Japan's Top-selling Drug; Mevalotin Falls to 3rd
July 4, 2005
- REGULATORY NEWS IN BRIEF
July 4, 2005
- Generic Substitution Only Speculation at This Point: Mr Futagawa
June 27, 2005
- REGULATORY NEWS IN BRIEF
June 27, 2005
- Chugai to Establish New Strategic Marketing Unit in July
June 27, 2005
- Healthnet to Enter Chinese Market with NDA Support Business
June 27, 2005
- Mattson Jack Group to Strengthen Support in Field of Oncology
June 27, 2005
- Takeda Leads Image Ranking among Clinicians: Nikkei BP Survey
June 27, 2005
- BUSINESS NEWS IN BRIEF
June 27, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…